These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20494963)

  • 1. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma.
    Bendandi M; Marillonnet S; Kandzia R; Thieme F; Nickstadt A; Herz S; Fröde R; Inogés S; Lòpez-Dìaz de Cerio A; Soria E; Villanueva H; Vancanneyt G; McCormick A; Tusé D; Lenz J; Butler-Ransohoff JE; Klimyuk V; Gleba Y
    Ann Oncol; 2010 Dec; 21(12):2420-2427. PubMed ID: 20494963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations.
    Caspar CB; Levy S; Levy R
    Blood; 1997 Nov; 90(9):3699-706. PubMed ID: 9345055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C; Simon F; Zirlik K; Heining-Mikesch K; Pfeifer D; Osterroth F; Rosenthal FM; Veelken H
    Eur J Haematol; 2006 Nov; 77(5):395-402. PubMed ID: 16879605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
    McCormick AA; Reddy S; Reinl SJ; Cameron TI; Czerwinkski DK; Vojdani F; Hanley KM; Garger SJ; White EL; Novak J; Barrett J; Holtz RB; Tusé D; Levy R
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10131-6. PubMed ID: 18645180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.
    Singh G; Parker S; Hobart P
    Vaccine; 2002 Jan; 20(9-10):1400-11. PubMed ID: 11818159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiotype vaccine production using hybridoma technology.
    Inoges S; de Cerio AL; Villanueva H; Pastor F; Bendandi M
    Methods Mol Biol; 2014; 1139():367-87. PubMed ID: 24619694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig.
    McCormick AA; Reinl SJ; Cameron TI; Vojdani F; Fronefield M; Levy R; Tusé D
    J Immunol Methods; 2003 Jul; 278(1-2):95-104. PubMed ID: 12957399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
    Timmerman JM
    Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
    [No Abstract]   [Full Text] [Related]  

  • 9. Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma.
    Patel KG; Ng PP; Levy S; Levy R; Swartz JR
    Protein Expr Purif; 2011 Jan; 75(1):15-20. PubMed ID: 20851769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond.
    Yusibov V; Streatfield SJ; Kushnir N
    Hum Vaccin; 2011 Mar; 7(3):313-21. PubMed ID: 21346417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA; Di Nicola M; Carlo-Stella C; Siena S; Gianni AM
    Curr Gene Ther; 2005 Oct; 5(5):511-21. PubMed ID: 16250891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
    Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA
    Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
    Ashour AK; Petersen JL; McIlhaney MM; Vose JM; Solheim JC
    Hybridoma (Larchmt); 2006 Oct; 25(5):306-8. PubMed ID: 17044787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of the purification process of a tumour-targeting antibody produced in N. benthamiana using vacuum-agroinfiltration.
    Lombardi R; Villani ME; Di Carli M; Brunetti P; Benvenuto E; Donini M
    Transgenic Res; 2010 Dec; 19(6):1083-97. PubMed ID: 20229286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.
    Betting DJ; Kafi K; Abdollahi-Fard A; Hurvitz SA; Timmerman JM
    J Immunol; 2008 Sep; 181(6):4131-40. PubMed ID: 18768870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.
    Reinis M
    Curr Opin Mol Ther; 2007 Jun; 9(3):291-8. PubMed ID: 17608028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
    Park HJ; Neelapu SS
    Br J Haematol; 2008 Jun; 142(2):179-91. PubMed ID: 18422783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco derived cancer vaccines for non-Hodgkin's lymphoma: perspectives and progress.
    McCormick AA
    Hum Vaccin; 2011 Mar; 7(3):305-12. PubMed ID: 21346416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine.
    Cha SC; Qin H; Sakamaki I; Kwak L
    Methods Mol Biol; 2014; 1139():289-303. PubMed ID: 24619688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.